Literature DB >> 1675611

CD4+ memory T cells in peripheral blood are not decreased in patients with atopic dermatitis.

J Burgard1, V Mielke, G Leimenstoll, W Sterry.   

Abstract

Atopic dermatitis (AD) is a severe and chronic eczematous skin disease, to which increased IgE levels and imbalances of CD4+ T cells are related. CD4+ T cells, however, are heterogeneous and include at least two subpopulations being designated as CD4+ naive and memory T cells. They represent sequential maturational stages (naive into memory) in CD4+ T cell development differing in function and phenotype. Of these two subpopulations the CD4+ memory T cell compartment is a potent producer of gamma-interferon which suppresses IgE synthesis in B cells. Therefore, we speculated whether an inborn maturation defect of CD4+ memory T cells causes the increased IgE production in AD. In patients with AD and age- and sex-matched controls (both n = 10) we analyzed the distribution of both subpopulations in peripheral blood by two-color flow cytometry using monoclonal antibodies against the CD4, CD45RA and CD29 antigen. We provide evidence that the numerical values of CD4+ memory T cells and CD4+ naive T cells are equivalent in both groups. This supports the view that functional disturbances of lymphocytes or lymphocyte subsets are responsible for IgE excess and the pathogenesis of AD.

Entities:  

Mesh:

Year:  1991        PMID: 1675611     DOI: 10.1159/000247751

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  2 in total

1.  Immunophenotyping of the cellular infiltrate in the early elicitation phase of contact dermatitis in the skin of presensitized atopic individuals.

Authors:  E M Garmann; H P Gollnick
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

2.  Imbalance of CD4+CD29+ and CD4+CD45RA+ T-helper cell subsets in peripheral blood of patients with severe atopic dermatitis.

Authors:  K Jung; A Bittrich; V Klimmek; H Schubert
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.